Congenital Malformations: Agreement Between Diagnostic Codes in an Administrative Database and Mothers' Reports

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 6, 2010, Pages 549-554

  Kulaga, Sophie ^a,b   Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Administrative database; Congenital malformations; Diagnostic codes; Quebec Pregnancy Registry; Validation

Indexed keywords

ADMINISTRATIVE CLAIMS (HEALTH CARE); ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOTHER; QUESTIONNAIRE; RANDOM SAMPLE; REGISTER; VALIDITY; CANADA; CONGENITAL DISORDER; INTERNATIONAL CLASSIFICATION OF DISEASES; PREGNANCY;

ADULT; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PREGNANCY; QUEBEC; QUESTIONNAIRES; REGISTRIES;

EID: 77957254181     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34523-6     Document Type: Article

References (13)

1. Bérard A., Ramos E., Rey E., Blais L., St-Andre M., Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007, 80:18-27.
2. Ofori B., Rey E., Bérard A. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol 2007, 64:496-509.
3. Wilchesky M., Tamblyn R.M., Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004, 57:131-141.
4. Ramos E., St-Andre M., Rey E., Oraichi D., Bérard A. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008, 192:344-350.
5. Vilain A., Otis S., Forget A., Blais L. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf 2008, 17:345-353.
6. Kulaga S., Zargarzadeh A.H., Bérard A. Prescriptions filled during pregnancy for drugs with the potential of fetal harm. BJOG 2009, 116:1788-1795.
7. Olson J.E., Shu X.O., Ross J.A., Pendergrass T., Robison L.L. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol 1997, 145:58-67.
8. Troude P., L'Helias L.F., Raison-Boulley A.M., Castel C., Pichon C., Bouyer J., et al. Perinatal factors reported by mothers: do they agree with medical records?. Eur J Epidemiol 2008, 23:557-564.
9. Rasmussen S.A., Mulinare J., Khoury M.J., Maloney E.K. Evaluation of birth defect histories obtained through maternal interviews. Am J Hum Genet 1990, 46:478-485.
10. Axelsson G., Rylander R. Validation of questionnaire reported miscarriage, malformation and birth weight. Int J Epidemiol 1984, 13:4-98.
11. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354:2443-2451.
12. Feldkamp M., Macleod L., Young L., Lecheminant K., Carey J.C. The methodology of the Utah Birth Defect Network: congenital heart defects as an illustration. Birth Defects Res A Clin Mol Teratol 2005, 73:693-699.
13. Piper J.M., Mitchel E.F., Snowden M., Hall C., Adams M., Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol 1993, 137:758-768.